Suphiya Parveen

3.9k total citations · 2 hit papers
16 papers, 2.8k citations indexed

About

Suphiya Parveen is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Suphiya Parveen has authored 16 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Biomaterials and 4 papers in Pharmaceutical Science. Recurrent topics in Suphiya Parveen's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (6 papers) and Advanced Drug Delivery Systems (4 papers). Suphiya Parveen is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (6 papers) and Advanced Drug Delivery Systems (4 papers). Suphiya Parveen collaborates with scholars based in India. Suphiya Parveen's co-authors include Sanjeeb Kumar Sahoo, Ranjita Misra, Jiban Jyoti Panda, Rizwan Hasan Khan, Basir Ahmad, K Krishnakumar, Savita Savita, Dhananjay Kumar Yadav, Fahima Dilnawaz and Ajay Kumar and has published in prestigious journals such as Biomacromolecules, European Journal of Pharmacology and Clinical Pharmacokinetics.

In The Last Decade

Suphiya Parveen

13 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging

2011 1.1k citations Suphiya Parveen, Ranjita Misra et al. Nanomedicine Nanotechnology Biology and Medicine profile →
The present and future of nanotechnology in human health care

2007 601 citations Sanjeeb Kumar Sahoo, Suphiya Parveen et al. Nanomedicine Nanotechnology Biology and Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suphiya Parveen India	8	1.1k	939	918	679	398	16	2.8k
Ranjita Misra India	16	1.2k 1.0×	944 1.0×	1.0k 1.1×	608 0.9×	306 0.8×	26	2.8k
Xiaoning Zhang China	27	1.2k 1.1×	1.0k 1.1×	1.2k 1.3×	725 1.1×	232 0.6×	59	3.2k
Fei Xiong China	29	1.1k 1.0×	988 1.1×	1.0k 1.1×	551 0.8×	225 0.6×	110	2.9k
Guangze Yang Australia	28	1.1k 0.9×	1.0k 1.1×	969 1.1×	520 0.8×	380 1.0×	62	2.9k
Dong M. Shin United States	7	1.6k 1.4×	1.1k 1.1×	1.2k 1.3×	484 0.7×	210 0.5×	11	2.8k
Jiasheng Tu China	30	971 0.8×	988 1.1×	1.2k 1.3×	329 0.5×	539 1.4×	97	2.9k
Dhruba J. Bharali United States	33	1.2k 1.1×	1.5k 1.6×	1.2k 1.3×	1.3k 1.9×	293 0.7×	64	4.4k
Yong Sun China	34	875 0.8×	1.1k 1.2×	1.7k 1.9×	977 1.4×	245 0.6×	150	3.9k
Zhenqing Hou China	34	1.8k 1.5×	1.1k 1.2×	1.9k 2.1×	795 1.2×	339 0.9×	113	3.5k

Countries citing papers authored by Suphiya Parveen

Since Specialization

Citations

This map shows the geographic impact of Suphiya Parveen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suphiya Parveen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suphiya Parveen more than expected).

Fields of papers citing papers by Suphiya Parveen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suphiya Parveen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suphiya Parveen. The network helps show where Suphiya Parveen may publish in the future.

Co-authorship network of co-authors of Suphiya Parveen

This figure shows the co-authorship network connecting the top 25 collaborators of Suphiya Parveen. A scholar is included among the top collaborators of Suphiya Parveen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suphiya Parveen. Suphiya Parveen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Parveen, Suphiya, et al.. (2025). Nanoimmunotherapy: the smart trooper for cancer therapy. Exploration of Targeted Anti-tumor Therapy. 6. 1002308–1002308. 2 indexed citations

Kumar, Ajay, et al.. (2024). A novel swarm-intelligent based gated recurrent unit for classifying and diagnosing diabetes mellitus patients. Multidisciplinary Science Journal. 6. 2024ss0603–2024ss0603.

Parveen, Suphiya, et al.. (2024). Recent Advancement of Nanotheranostics in Cancer Applications. Current Drug Delivery. 22(8). 1073–1091. 3 indexed citations

Parveen, Suphiya, et al.. (2024). AI for Agro-Business in the Identification of Rice Diseases. 976–982. 2 indexed citations

Pandya, Apurvakumar, et al.. (2023). The influence of cultural competence on healthcare outcomes. Salud Ciencia y Tecnología. 3. 445–445.

Parveen, Suphiya, et al.. (2023). MANAGING ARTHRITIS PAIN: MEDICATIONS AND LIFESTYLE CHANGES.. PubMed. 117–122. 1 indexed citations

Parveen, Suphiya, et al.. (2023). Advanced AI Approaches for Detailed Examination of Individuals Prone to Nightly Respiratory Challenges Using Medical Records. 1–6. 2 indexed citations

Parveen, Suphiya, et al.. (2021). In Vitro and In Vivo Analysis of Fentanyl and Fentalog Metabolites using Hyphenated Chromatographic Techniques: A Review. Chemical Research in Toxicology. 35(1). 30–42. 3 indexed citations

Parveen, Suphiya & Sanjeeb Kumar Sahoo. (2011). Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. European Journal of Pharmacology. 670(2-3). 372–383. 238 indexed citations

10.

Parveen, Suphiya, Ranjita Misra, & Sanjeeb Kumar Sahoo. (2011). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine Nanotechnology Biology and Medicine. 8(2). 147–166. 1093 indexed citations breakdown →

11.

Parveen, Suphiya & Sanjeeb Kumar Sahoo. (2010). Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma. Cancer Nanotechnology. 1(1-6). 47–62. 58 indexed citations

12.

Parveen, Suphiya & Sanjeeb Kumar Sahoo. (2008). Polymeric nanoparticles for cancer therapy. Journal of drug targeting. 16(2). 108–123. 308 indexed citations

13.

Sahoo, Sanjeeb Kumar, Suphiya Parveen, & Jiban Jyoti Panda. (2007). The present and future of nanotechnology in human health care. Nanomedicine Nanotechnology Biology and Medicine. 3(1). 20–31. 601 indexed citations breakdown →

14.

Parveen, Suphiya & Sanjeeb Kumar Sahoo. (2006). Nanomedicine. Clinical Pharmacokinetics. 45(10). 965–988. 133 indexed citations

15.

Parveen, Suphiya, K Krishnakumar, & Sanjeeb Kumar Sahoo. (2006). New Era in Health Care: Tissue Engineering. PubMed. 1(1). 8–24. 31 indexed citations

16.

Ahmad, Basir, Suphiya Parveen, & Rizwan Hasan Khan. (2006). Effect of Albumin Conformation on the Binding of Ciprofloxacin to Human Serum Albumin: A Novel Approach Directly Assigning Binding Site. Biomacromolecules. 7(4). 1350–1356. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact